vimarsana.com
Home
Live Updates
Genenta Science S p A : Consolidated Statements of Operation
Genenta Science S p A : Consolidated Statements of Operation
Genenta Science S p A : Consolidated Statements of Operations and Comprehensive Loss - Form 6-K -October 20, 2023 at 04:55 pm EDT
Genenta Science S.p.A.
Consolidated Statements of Operations and Comprehensive Loss
Six Months Ended June...
Related Keywords
Russia ,
United States ,
Delaware ,
Milan ,
Lombardia ,
Italy ,
Bresso ,
Ukraine ,
America ,
Italian ,
Bernhard Gentner ,
Richard Slansky ,
Carlo Russo ,
Imposta Sul Valore Aggiunto ,
Institut Pasteur ,
Pierluigi Paracchi ,
Raffaele Hospitalas ,
Bernard Rudolph Gentner ,
Luigi Naldini ,
Manufacturing Service Agreement ,
Company Of Theravecty ,
Master Service Agreement ,
Head Of Development ,
Company Board Of Directors The ,
Framework Service Agreement ,
Company Equity Incentive Plan ,
Glaxosmithkline Intellectual Property Development ,
European Commission ,
International Accounting Standards ,
Cantor Fitzgerald Co ,
Company Is Euros ,
Research Agreementon ,
Exchange Commission ,
Genenta Science Inc ,
Company At ,
Company Annual ,
Nasdaq ,
Research Agreement ,
Company Consolidated Statements Of Operations ,
Company Annual Report On Form ,
Company Or Genenta ,
Investment Company ,
Months Ended June ,
Consolidated Financial ,
San Raffaele Hospital ,
Genenta Science ,
Nasdaq Stock Capital Market ,
Depository Shares ,
Controlled Equity ,
Cantor Fitzgerald ,
Sales Agreement ,
Renal Cell Cancer ,
Investment Company Act ,
Regulations X ,
Accounting Standards Codification ,
Accounting Standards Update ,
Financial Accounting Standards Board ,
Annual Report ,
Equity Incentive Plan ,
Consolidated Statements ,
Jumpstart Our Business Startups Act ,
Government Grants ,
Incentive Plan ,
Consolidated Statement ,
Comprehensive Loss ,
Income Taxes ,
Government Assistance ,
Business Entities ,
Own Equity ,
Convertible Instruments ,
Related Parties ,
Valore Aggiunto ,
Fine Rapporto ,
Consumer Price Index ,
Benefits The ,
Black Scholes ,
Average Remaining Contractual Term ,
Raffaele Hospital ,
Rudolph Gentner ,
Chief Medical Officer ,
Chief Financial Officer ,
San Raffaele ,
Chief Executive Officer ,
Scientific Advisory Board ,
License Agreement ,
Law Decree ,
Italian Golden Power ,
Adoption Fee ,
Royalty Term ,
Side Letter ,
Process Transfer Agreement ,
Tech Transfer ,
Research Agreementon August ,
Sponsored Research Agreement ,
Candidate Products ,
Markets ,